Literature DB >> 16259166

Outcome after transthoracic resection of carcinoma of the oesophagus and oesophago-gastric junction.

L S Jensen1, H K Pilegaard, E Puho, E Pahle, N C Melsen.   

Abstract

AIMS: To assess the postoperative morbidity and mortality, length of stay and long-term survival after resection of carcinoma of the oesophagus and gastro-oesophageal junction, after establishment of a new surgical team unit between thoracic and gastroenterologic surgeons.
METHODS: We analysed the prospective collected data of 166 consecutive patients who underwent a transthoracic oesophageal resection between June 1997 and December 2003.
RESULTS: There were 119 men and 47 women. The median age was 63 years (range 36-81). Fifty-five patients (33%) had squamous cell carcinoma and 111 (67%) had adenocarcinoma. Postoperative complications occurred in a total of 60 patients (36%). Ten patients (6%) died postoperatively, eight (4.8%) due to medical and two (1.2 %) due to surgical complications. The median postoperative length of stay was 11 days (range 6-75). The overall 3- and 5- years survival was 35.6% and 30.6% respectively. Survival was adversely affected by patient age and tumor stage.
CONCLUSIONS: Concentrating resection for carcinoma of the oesophagus and oesophagogastric junction to a dedicated team of specialists, including both gastrointestinal and thoracic surgeons as well as thoracic-anaesthesiological know-how, results in acceptable complication rates as well as low mortality rates especially due to surgical complications.

Entities:  

Mesh:

Year:  2005        PMID: 16259166     DOI: 10.1177/145749690509400303

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  4 in total

1.  Survival trends in gastric cancer patients of Northeast China.

Authors:  Hao Zhang; Ling-Ling Sun; Yan-Li Meng; Guang-Yu Song; Jing-Jing Hu; Ping Lu; Bin Ji
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

Review 2.  Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis.

Authors:  Ming-Tian Wei; Yuan-Chuan Zhang; Xiang-Bing Deng; Ting-Han Yang; Ya-Zhou He; Zi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study.

Authors:  Sarah J Crane; G Richard Locke; William S Harmsen; Alan R Zinsmeister; Yvonne Romero; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

4.  Transthoracic versus abdominal-transhiatal resection for treating Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis.

Authors:  Zhi Zheng; Jun Cai; Jie Yin; Jun Zhang; Zhong-Tao Zhang; Kang-Li Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.